市場調査レポート
商品コード
1373778
実践療法の世界市場 - 市場規模、シェア、成長分析:製品タイプ別(陽子線治療、重粒子線治療)、コンポーネント別(製品、サービス) - 業界予測(2023年~2030年)Global Practice Therapy Market Size, Share, Growth Analysis, By Type(proton therapy, heavy ion therapy), By Component(Product and Service) - Industry Forecast 2023-2030 |
実践療法の世界市場 - 市場規模、シェア、成長分析:製品タイプ別(陽子線治療、重粒子線治療)、コンポーネント別(製品、サービス) - 業界予測(2023年~2030年) |
出版日: 2023年10月27日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
|
実践療法の市場規模は2021年に4,383億3,000万米ドル、2022年に4,981億6,000万米ドルとなりました。同市場は、予測期間中(2023年~2030年)に13.65%のCAGRで拡大し、2030年には1兆3,865億2,000万米ドルに成長する見通しです。
実践療法市場促進要因のひとつは、世界のがん罹患率の上昇です。がんの有病率は上昇を続けており、実践療法は、脳、脊髄、小児症例などの繊細な領域に位置する腫瘍を含む、さまざまな種類の腫瘍を治療するための有望なソリューションを提供しています。周囲の健康な組織を温存しながら腫瘍に高線量を照射できることが、実践療法が採用される大きな要因となっています。さらに、実践療法における技術の進歩や革新が市場の成長を後押ししています。より小型で費用対効果の高い陽子線治療システムの開発により、この治療法はヘルスケアプロバイダーや患者にとってより身近なものとなっています。
世界のがん罹患率の上昇は、実践療法市場の重要な促進要因です。実践療法は、さまざまな種類の腫瘍に対して効果的で正確な治療法を提供するため、患者やヘルスケアプロバイダーからの需要が高まっています。
実践療法システム、治療計画ソフトウェア、画像技術における継続的な技術進歩により、治療の精度、有効性、患者の転帰が改善されています。小型で費用対効果の高い陽子線治療システムや画像診断モダリティの統合などの革新により、市場の可能性が拡大しています。
当レポートは、世界の実践療法市場について調査し、市場の概要とともに、製品タイプ別、コンポーネント別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。
Practice Therapy Market size was valued at USD 438.33 Billion in 2021 and is poised to grow from USD 498.16 Billion in 2022 to USD 1386.52 Billion by 2030, at a CAGR of 13.65% during the forecast period (2023-2030).
One of the key drivers boosting the practice therapy market is the increasing incidence of cancer worldwide. The prevalence of cancer continues to rise, and Practice therapy offers a promising solution for treating various types of tumors, including those located in sensitive areas such as the brain, spinal cord, and pediatric cases. The ability of practice therapy to deliver higher radiation doses to tumors while sparing surrounding healthy tissues has been a significant factor in its adoption. Moreover, technological advancements and innovations in Practice therapy have fueled market growth. The development of more compact and cost-effective proton therapy systems has made this treatment modality more accessible to healthcare providers and patients.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Practice Therapy Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Practice Therapy Market Segmental Analysis
The global practice therapy market is segmented on the basis of type, component, and region. By type, the market is segmented into proton therapy, heavy ion therapy, and fast-neutron therapy. By component, the market is segmented into product, and service. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Practice Therapy Market Dynamics
Practice Therapy Market Drivers
Increasing Prevalence of Cancer
Technological Advancements
Practice Therapy Market Restraints
Reimbursement Challenges
Limited Accessibility
Market Trends of Global Practice Therapy Market
Hypofractionation refers to the delivery of higher radiation doses per treatment session, resulting in a shorter overall treatment duration. This approach is gaining traction in Practice therapy as studies suggest that hypofractionation can be as effective as conventional fractionation while reducing treatment time and improving patient convenience.
AI and ML technologies are being integrated into Practice therapy systems and treatment planning software to enhance treatment precision and efficiency. These technologies can assist in automated treatment planning, adaptive therapy, and real-time monitoring, enabling personalized treatment approaches and improving patient outcomes.